Madhya Pradesh

The Institute activities started in the month of April 1970 and continued up to April 1979 under Composite Drug Research Scheme. It was established initially as Regional Research Institute (Ay.) in 1979 with the merger of survey of Medicinal Plants Unit (SMPU), Mobile Clinical Research Unit (MCRU) in addition to Community Health Care Research Programme. The Institute was upgraded as Central Research Institute (Ay.) in 1999. The Institute has shifted to its own building in August 2002.

A pharmaceutical generics business company. HPRA Approved (April 2021) facility for veterinary generic medicines. Parent entity based in Ireland.

QUALITY CONTROL (OSD)

Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conductinnovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

IPCA LABORATORIES LIMITED is an Indian multinational pharmaceutical company. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules and sells these formulations domestic and global market. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents.

Torrent Pharma, the flagship company of Torrent Group, is one leading pharma companies in the country. Torrent is all poised to spread wings across globe with strong technical capabilities and international accreditations.

Kusum Healthcare Pvt. Ltd. is a part of the Kusum group of companies which is a fully integrated, young pharmaceutical group having three manufacturing units; Kusum Healthcare at Bhiwadi Rajasthan, Kusum Healthcare at Indore, Madhya Pradesh in India and Kusum Pharm at Sumy Ukraine. All these manufacturing units are WHO GMP certified and PIC/s compliant.

AIIMS Bhopal is an apex healthcare institute, established by the Ministry of Health and Family Welfare, Government of India under the Pradhan Mantri Swasthya Suraksha Yojna (PMSSY) with the aim of correcting regional imbalances in quality tertiary level healthcare in the country and attaining self-sufficiency in graduate and postgraduate medical education and training.

CSIR-Central Drug Research Institute, Lucknow, a premier Institute under Council of Scientific and Industrial Research (CSIR), is involved in multidisciplinary R&D programs of both basic and applied nature. CSIR-CDRI is a pioneer biomedical research organization in India and has the infrastructure and expertise to develop a drug from concept to commercialization. In the year 2012, CSIR-CDRI shifted to its state of the art new campus, which has been set up with a vision to serve as a Nodal Center of CSIR in new drug discovery and development.

The AIIMS, New Delhi model will be adopted and adapted. Unlike the Postgraduate Institutes which lack the basic departments like Anatomy, Physiology, Pharmacology, General Medicine, Surgery, Obstetrics & Gynaecology etc, the new AIIMS will have these departments as well as the superspecialty departments like neurosurgery, cardiac surgery, urology, endocrinology etc.